Research Row: Approved or on the Horizon Join us as we discuss Approved Therapies and those on the Horizon of approval. Santhera Pharmaceuticals (Vamorolone) Italfarmaco ( Givinostat) PTC Pharmaceuticals (Ataluren, Emflaza) Sarepta Therapeutics (Amondys45, Exondys 51, Vyondys53) NS Pharma (Viltepso) 2023 PPMD Annual Conference,Conferences & Meetings 1 year ago You may also like 30:00 Keynote: Resilience – PPMD 2024 Annual Conference 1 month ago 2024 PPMD Annual Conference,Conferences & Meetings 43:27 Current Approved Therapies Panel & Discussion (Pt. 2) – PPMD 2024 Annual Conference 1 month ago 2024 PPMD Annual Conference,Conferences & Meetings 57:45 Sleep & Behavior: How They Impact Each Other – PPMD 2024 Annual Conference 1 month ago 2024 PPMD Annual Conference,Conferences & Meetings 55:59 Decision Making around Steroids, Weight, and Nutrition – PPMD 2024 Annual Conference 1 month ago 2024 PPMD Annual Conference,Conferences & Meetings 47:28 Panel Conversation: The Little Things Matter – PPMD 2024 Annual Conference 1 month ago 2024 PPMD Annual Conference,Conferences & Meetings 36:59 OptimizeDMD: Moving the Dial in Endocrinology & Bone – PPMD 2024 Annual Conference 1 month ago 2024 PPMD Annual Conference,Conferences & Meetings 47:56 Research Row: Approaches to Alter Progression – PPMD 2024 Annual Conference 1 month ago 2024 PPMD Annual Conference,Conferences & Meetings 48:44 Clinical Trials: A Panel Discussion on the Developmental Path – PPMD 2024 Annual Conference 1 month ago 2024 PPMD Annual Conference,Conferences & Meetings «1234…25»Page 2 of 25